SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-021995
Filing Date
2020-11-19
Accepted
2020-11-19 08:00:31
Documents
24
Period of Report
2020-11-19
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38537
2 ex99-1.htm EX-99.1 853
3 ex99-2.htm EX-99.2 37542
4 ex99-3.htm EX-99.3 4876
5 ex99-1_001.jpg GRAPHIC 2527342
6 ex99-3_001.jpg GRAPHIC 76124
7 ex99-3_002.jpg GRAPHIC 200363
8 ex99-3_003.jpg GRAPHIC 157464
9 ex99-3_004.jpg GRAPHIC 75720
10 ex99-3_005.jpg GRAPHIC 99947
11 ex99-3_006.jpg GRAPHIC 107421
12 ex99-3_007.jpg GRAPHIC 63598
13 ex99-2_001.jpg GRAPHIC 2784
  Complete submission text file 0001493152-20-021995.txt   4824973

Data Files

Seq Description Document Type Size
14 XBRL SCHEMA FILE vbiv-20201119.xsd EX-101.SCH 3195
15 XBRL LABEL FILE vbiv-20201119_lab.xml EX-101.LAB 34591
16 XBRL PRESENTATION FILE vbiv-20201119_pre.xml EX-101.PRE 22716
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3632
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 201327114
SIC: 2834 Pharmaceutical Preparations